Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Minutolo

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Medicina (Kaunas, Lithuania)|June 20, 2019
SGLT2 Inhibitors: Nephroprotective Efficacy and Side EffectsCarlo Garofalo, Silvio Borrelli, Maria Elena Liberti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 15, 2025
Cost-effectiveness of protein restricted diets in advanced CKDVincenzo Bellizzi, Mario Fordellone, Luca De Nicola, et al.
Journal of Nephrology|February 15, 2011
Hypertension management in chronic kidney disease: translating guidelines into daily practiceLuca De Nicola, Silvio Borrelli, Paolo Chiodini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Achievement of target blood pressure levels in chronic kidney disease: a salty question?Luca De Nicola, Roberto Minutolo, Vincenzo Bellizzi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2020
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney diseaseRoberto Minutolo, Carlo Garofalo, Paolo Chiodini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 10, 2014
[Prevention of diabetic nephropathy: from bench to bedside]Maria Elena Liberti, Adelia Sagliocca, Raffaele Palmisano, et al.
Nutrients|April 13, 2023
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-AnalysisCarlo Garofalo, Chiara Ruotolo, Claudia Annoiato, et al.
European Journal of Internal Medicine|November 15, 2011
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-upPierangela Presta, Roberto Minutolo, Carmela Iodice, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 13, 2008
Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from ItalyRoberto Minutolo, Luca De Nicola, Giampiero Mazzaglia, et al.
Blood Purification|September 11, 2004
Efficacy of erythropoietin on dialysis in patients with beta thalassemia minorBiagio Di Iorio, Luca De Nicola, Vincenzo Bellizzi, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Medicina (Kaunas, Lithuania)|June 20, 2019
SGLT2 Inhibitors: Nephroprotective Efficacy and Side EffectsCarlo Garofalo, Silvio Borrelli, Maria Elena Liberti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 15, 2025
Cost-effectiveness of protein restricted diets in advanced CKDVincenzo Bellizzi, Mario Fordellone, Luca De Nicola, et al.
Journal of Nephrology|February 15, 2011
Hypertension management in chronic kidney disease: translating guidelines into daily practiceLuca De Nicola, Silvio Borrelli, Paolo Chiodini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Achievement of target blood pressure levels in chronic kidney disease: a salty question?Luca De Nicola, Roberto Minutolo, Vincenzo Bellizzi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2020
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney diseaseRoberto Minutolo, Carlo Garofalo, Paolo Chiodini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 10, 2014
[Prevention of diabetic nephropathy: from bench to bedside]Maria Elena Liberti, Adelia Sagliocca, Raffaele Palmisano, et al.
Nutrients|April 13, 2023
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-AnalysisCarlo Garofalo, Chiara Ruotolo, Claudia Annoiato, et al.
European Journal of Internal Medicine|November 15, 2011
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-upPierangela Presta, Roberto Minutolo, Carmela Iodice, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 13, 2008
Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from ItalyRoberto Minutolo, Luca De Nicola, Giampiero Mazzaglia, et al.
Blood Purification|September 11, 2004
Efficacy of erythropoietin on dialysis in patients with beta thalassemia minorBiagio Di Iorio, Luca De Nicola, Vincenzo Bellizzi, et al.
Pageof 18